What is Ana Marie Liolios's NPI number?

Ana Marie Liolios's National Provider Identifier (NPI) is 1932338746, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Ana Marie Liolios's specialty?

Ana Marie Liolios is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Ana Marie Liolios located?

Ana Marie Liolios's practice location on file with NPPES is 5204 N Belt Hwy, Saint Joseph, MO 64506-1211.

What is Ana Marie Liolios's phone number?

The practice phone number listed in the NPPES registry for Ana Marie Liolios is (816) 383-8180.

Does Ana Marie Liolios accept Medicare?

Ana Marie Liolios is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Ana Marie Liolios's NPI active?

Yes — Ana Marie Liolios's NPI (1932338746) is active in the NPPES registry as of the last update on 2014-10-03.

IndividualActiveAccepts Medicare

Ana Marie Liolios, MD

NPI 1932338746 · Dermatology Physician · Saint Joseph, MO

Ana Marie Liolios, MD is a Dermatology Physician provider in Saint Joseph, MO (NPI 1932338746).

Provider details

NPI number: 1932338746
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: No
License: 2014028853 (MO)

Practice location

5204 N Belt Hwy

Plastic Surgery and Dermatology

Saint Joseph, MO 64506-1211

Phone: (816) 383-8180

Street-level locationGet directions

More MO providers

Mailing address

5204 N Belt Hwy

Saint Joseph, MO 64506-1211

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 2014028853 (MO)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense A126772 (CA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(79/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
17 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
4,041 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,319	$2
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	777	$62
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	542	$91
Destruction of Precancer Skin Growth, 1 Growth17000	492	$43
Destruction of Skin Growth, 1-14 Growths17110	325	$60
Biopsy of Related Skin Growth, First Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	74	32
Doxycycline Hyclate	41	27
Clobetasol Propionate	40	25
Triamcinolone Acetonide	32	30
Fluorouracil	29	27
Nystatin	25	16
Mupirocin	23	21
Clindamycin Phosphate	21	13

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$76 across 3 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2009-07-14
Last updated: 2014-10-03

Frequently asked questions

What is Ana Marie Liolios's NPI number?: Ana Marie Liolios's National Provider Identifier (NPI) is 1932338746, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Ana Marie Liolios's specialty?: Ana Marie Liolios is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Ana Marie Liolios located?: Ana Marie Liolios's practice location on file with NPPES is 5204 N Belt Hwy, Saint Joseph, MO 64506-1211.
What is Ana Marie Liolios's phone number?: The practice phone number listed in the NPPES registry for Ana Marie Liolios is (816) 383-8180.
Does Ana Marie Liolios accept Medicare?: Ana Marie Liolios is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Ana Marie Liolios's NPI active?: Yes — Ana Marie Liolios's NPI (1932338746) is active in the NPPES registry as of the last update on 2014-10-03.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,319	$2
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	777	$62
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	542	$91
Destruction of Precancer Skin Growth, 1 Growth17000	492	$43
Destruction of Skin Growth, 1-14 Growths17110	325	$60
Biopsy of Related Skin Growth, First Growth

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

Doxycycline Hyclate

Clobetasol Propionate

Triamcinolone Acetonide

Fluorouracil

Nystatin

Mupirocin

Clindamycin Phosphate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$76 across 3 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments